Clinical Approach to Diarrhea
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of Diarrhea
Diarrhea is one of the most common complaints encountered in primary care, accounting for approximately 179 million episodes annually in the United States alone. Globally, diarrheal diseases remain a leading cause of morbidity and mortality, responsible for approximately 1.6 million deaths per year worldwide. In developed countries, the average adult experiences 0.5 to 2 episodes of acute diarrhea per year, while chronic diarrhea affects approximately 3-5% of the adult population. The economic impact is substantial, with billions of dollars spent annually on healthcare costs, lost productivity, and over-the-counter remedies.
Definition
Diarrhea is defined as the passage of three or more loose or liquid stools per day, or more frequent passage than is normal for the individual. The World Health Organization defines it as the passage of unusually loose or watery stools, usually at least three times in a 24-hour period. From a physiological standpoint, diarrhea represents an increase in stool weight above 200 grams per day, reflecting an imbalance between intestinal absorption and secretion of fluid and electrolytes.
Classification by Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute | Less than 14 days | Viral gastroenteritis, bacterial infection, food poisoning, medication side effects | Most common presentation; usually self-limiting; focus on hydration and identifying severe cases |
| Persistent | 14 to 28 days | Protozoal infections (Giardia, Cryptosporidium), post-infectious irritable bowel syndrome, Clostridioides difficile | Warrants further investigation; consider parasitic causes and post-infectious syndromes |
| Chronic | Greater than 28 days | Inflammatory bowel disease, irritable bowel syndrome, malabsorption syndromes, microscopic colitis | Requires systematic workup; significant impact on quality of life; often multifactorial |
Classification by Character
Watery Diarrhea
Description: Large volume, liquid stools without blood or mucus
Subdivisions:
- Secretory: Persists with fasting; caused by active secretion (cholera, carcinoid, VIPoma)
- Osmotic: Resolves with fasting; caused by unabsorbed solutes (lactose intolerance, sorbitol, magnesium)
Clinical Implication: High risk of dehydration and electrolyte disturbances
Inflammatory (Dysenteric) Diarrhea
Description: Small volume, frequent stools with blood, mucus, or pus
Features:
- Tenesmus (painful urge to defecate)
- Fever commonly present
- Lower abdominal cramping
Clinical Implication: Suggests mucosal invasion; requires stool studies and possible endoscopy
Fatty Diarrhea (Steatorrhea)
Description: Pale, bulky, foul-smelling, greasy stools that float and are difficult to flush
Causes: Malabsorption syndromes, pancreatic insufficiency, celiac disease, small intestinal bacterial overgrowth
Clinical Implication: Indicates fat malabsorption; evaluate for pancreatic and small bowel pathology
Functional Diarrhea
Description: Chronic, painless, loose stools without organic cause
Features:
- Often alternates with normal stools
- No nocturnal symptoms
- No weight loss or systemic features
Clinical Implication: Diagnosis of exclusion; part of functional bowel disorder spectrum
Classification by Pattern and Timing
| Pattern | Description | Suggests |
|---|---|---|
| Morning predominant | Urgency and multiple bowel movements upon waking, settling as day progresses | Irritable bowel syndrome (diarrhea-predominant) |
| Nocturnal diarrhea | Waking from sleep to defecate | Organic pathology (inflammatory bowel disease, diabetic autonomic neuropathy, microscopic colitis); argues against functional cause |
| Post-prandial | Diarrhea within 30-60 minutes of eating | Gastrocolic reflex hypersensitivity, dumping syndrome, bile acid malabsorption |
| Fasting-responsive | Diarrhea resolves or significantly improves with fasting | Osmotic diarrhea (lactose intolerance, dietary factors) |
| Continuous/persistent | Present regardless of meals or fasting | Secretory diarrhea, inflammatory bowel disease |
| Epidemic pattern | Multiple affected individuals with common exposure | Infectious outbreak (foodborne illness, waterborne pathogen) |
Stool Characteristics and Their Significance
| Characteristic | Description | Clinical Association |
|---|---|---|
| Bloody (hematochezia) | Visible fresh blood in stool | Invasive bacterial infection, inflammatory bowel disease, ischemic colitis, colorectal malignancy |
| Mucoid | Visible mucus coating or mixed with stool | Inflammatory bowel disease, irritable bowel syndrome, infectious colitis |
| Rice-water | Profuse, colorless, odorless watery stool | Cholera (classic presentation) |
| Greasy/floating | Oily, foul-smelling, difficult to flush | Steatorrhea from fat malabsorption |
| Explosive | Forceful expulsion with gas | Carbohydrate malabsorption, bacterial fermentation |
Key Concept: The Practical Classification Framework
When evaluating diarrhea, systematically consider three questions:
- Duration: Acute, persistent, or chronic? — This guides urgency and likely etiology
- Character: Watery, inflammatory, or fatty? — This suggests the pathophysiological mechanism
- Pattern: When does it occur? What makes it better or worse? — This narrows the differential
In acute diarrhea, approximately 90% of cases are infectious and self-limiting. In chronic diarrhea, the “Big Three” non-infectious causes are irritable bowel syndrome-diarrhea predominant (IBS-D), inflammatory bowel disease, and malabsorption syndromes — together accounting for the majority of cases requiring investigation.
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of Diarrhea
Understanding the pathophysiology of diarrhea is essential for rational diagnosis and treatment. Under normal conditions, approximately 9 liters of fluid enter the gastrointestinal tract daily — 2 liters from oral intake and 7 liters from secretions (saliva, gastric juice, bile, pancreatic juice, and intestinal secretions). The small intestine absorbs approximately 7.5 liters, and the colon absorbs another 1.3 liters, leaving only 100-200 mL excreted in stool. Diarrhea occurs when this balance is disrupted — either through increased secretion, decreased absorption, altered motility, or mucosal inflammation.
Normal Intestinal Fluid Handling
| Component | Daily Volume | Function |
|---|---|---|
| Oral intake | ~2,000 mL | Dietary fluid and water |
| Salivary secretion | ~1,500 mL | Lubrication, amylase, bicarbonate |
| Gastric secretion | ~2,500 mL | Acid, pepsin, intrinsic factor |
| Bile | ~500 mL | Fat emulsification, waste excretion |
| Pancreatic secretion | ~1,500 mL | Digestive enzymes, bicarbonate |
| Small intestinal secretion | ~1,000 mL | Enzymes, mucus, fluid |
| Total entering GI tract | ~9,000 mL | — |
| Small intestine absorption | ~7,500 mL | Primary site of nutrient and fluid absorption |
| Colonic absorption | ~1,300 mL | Final water and electrolyte salvage |
| Normal stool output | 100-200 mL | Water, undigested material, bacteria |
The Four Major Mechanisms of Diarrhea
1. Secretory Diarrhea
Mechanism: Active secretion of electrolytes and water into the intestinal lumen exceeds absorption capacity
Pathways:
- Cyclic AMP activation (cholera toxin, VIPoma)
- Cyclic GMP activation (E. coli heat-stable toxin)
- Increased intracellular calcium
Key Feature: Persists despite fasting; large volume (often >1 L/day); watery; low stool osmotic gap
2. Osmotic Diarrhea
Mechanism: Poorly absorbed, osmotically active solutes draw water into the intestinal lumen
Causes:
- Carbohydrate malabsorption (lactose, fructose, sorbitol)
- Magnesium-containing antacids or laxatives
- Polyethylene glycol laxatives
Key Feature: Resolves with fasting; high stool osmotic gap (>125 mOsm/kg)
3. Inflammatory Diarrhea
Mechanism: Mucosal damage impairs absorption and causes exudation of blood, mucus, and protein into the lumen
Features:
- Release of inflammatory mediators (prostaglandins, cytokines)
- Disruption of epithelial barrier
- Increased permeability
Key Feature: Blood, mucus, or pus in stool; fever; tenesmus; elevated fecal calprotectin and lactoferrin
4. Motility-Related Diarrhea
Mechanism: Altered intestinal transit time affects fluid absorption and bacterial overgrowth
Types:
- Rapid transit: Reduced contact time for absorption (hyperthyroidism, post-surgical)
- Slow transit: Bacterial overgrowth from stasis
Key Feature: Variable stool consistency; may be associated with bloating and cramping
Stool Osmotic Gap: A Diagnostic Tool
Formula: Stool Osmotic Gap = 290 − 2 × (stool Na+ + stool K+)
Interpretation:
- Low gap (<50 mOsm/kg): Secretory diarrhea — electrolytes account for most of stool osmolality
- High gap (>125 mOsm/kg): Osmotic diarrhea — unmeasured osmoles (unabsorbed solutes) present
- Intermediate (50-125 mOsm/kg): Mixed or uncertain mechanism
How Specific Conditions Cause Diarrhea
| Condition | Primary Mechanism | Pathophysiology | Treatment Implication |
|---|---|---|---|
| Viral gastroenteritis (Norovirus, Rotavirus) | Secretory + Osmotic | Enterocyte destruction reduces absorptive surface; villous blunting causes secondary disaccharidase deficiency | Supportive care; oral rehydration; temporary lactose avoidance may help |
| Cholera | Secretory | Cholera toxin permanently activates adenylate cyclase, causing massive chloride secretion via CFTR channels | Aggressive fluid replacement; oral rehydration solution exploits intact sodium-glucose cotransport |
| Clostridioides difficile infection | Inflammatory + Secretory | Toxins A and B cause epithelial cell death, inflammation, and pseudomembrane formation | Stop inciting antibiotics; targeted antimicrobial therapy (vancomycin, fidaxomicin) |
| Inflammatory bowel disease | Inflammatory | Chronic mucosal inflammation with cytokine release, epithelial disruption, and impaired absorption | Anti-inflammatory and immunomodulatory therapy |
| Lactose intolerance | Osmotic | Lactase deficiency leaves undigested lactose in lumen; bacterial fermentation produces gas and organic acids | Lactose restriction; lactase enzyme supplementation |
| Celiac disease | Osmotic + Malabsorptive | Gluten-triggered immune response causes villous atrophy, reducing absorptive surface area | Strict gluten-free diet |
| Bile acid malabsorption | Secretory | Excess bile acids in colon stimulate chloride and water secretion; accelerate colonic motility | Bile acid sequestrants (cholestyramine, colesevelam) |
| Small intestinal bacterial overgrowth | Osmotic + Malabsorptive | Excessive bacteria deconjugate bile acids and compete for nutrients; fermentation produces gas | Antibiotics (rifaximin); address underlying motility or anatomical cause |
| Carcinoid syndrome | Secretory + Motility | Serotonin and other mediators increase intestinal secretion and accelerate motility | Somatostatin analogues (octreotide) |
| Diabetic autonomic neuropathy | Motility + Bacterial overgrowth | Impaired intestinal motility leads to stasis and bacterial overgrowth; may have nocturnal diarrhea | Prokinetics; antibiotics for bacterial overgrowth; glycemic control |
| Microscopic colitis | Secretory + Inflammatory | Lymphocytic or collagenous inflammation impairs colonic absorption; may have secretory component | Budesonide; stop offending medications |
Infectious Pathogen Mechanisms
Toxin-Mediated (Non-invasive)
Pathogens: Vibrio cholerae, Enterotoxigenic E. coli, Staphylococcus aureus (preformed toxin), Bacillus cereus
Mechanism: Toxins alter enterocyte function without mucosal invasion
Stool: Watery, non-bloody
Site: Primarily small intestine
Invasive/Inflammatory
Pathogens: Shigella, Salmonella, Campylobacter, Enteroinvasive E. coli, Entamoeba histolytica
Mechanism: Direct mucosal invasion and destruction; inflammatory response
Stool: Bloody, mucoid, small volume
Site: Colon (dysentery pattern)
Adherent/Effacing
Pathogens: Enteropathogenic E. coli, Enterohemorrhagic E. coli (O157:H7)
Mechanism: Attach to enterocytes, efface microvilli; some produce Shiga toxin
Stool: Initially watery, may become bloody
Note: E. coli O157:H7 can cause hemolytic uremic syndrome
Special Pathophysiological Considerations
Post-infectious Irritable Bowel Syndrome
Following acute infectious gastroenteritis, 10-15% of patients develop chronic symptoms consistent with irritable bowel syndrome. Proposed mechanisms include:
- Persistent low-grade mucosal inflammation
- Altered gut microbiome composition
- Increased intestinal permeability
- Visceral hypersensitivity
- Altered serotonin signaling
The Role of the Microbiome
The gut microbiome (approximately 100 trillion bacteria) plays a critical role in maintaining intestinal homeostasis. Disruption can cause diarrhea through:
- Loss of colonization resistance allowing pathogen overgrowth
- Reduced short-chain fatty acid production (important for colonocyte nutrition)
- Impaired bile acid metabolism
- Altered immune regulation
Often Overlooked Mechanism: Bile Acid Diarrhea
Bile acid malabsorption is increasingly recognized as an underdiagnosed cause of chronic diarrhea, affecting up to 25-30% of patients labeled with “diarrhea-predominant irritable bowel syndrome.” It can be primary (idiopathic, due to defective ileal feedback regulation) or secondary (following ileal resection, cholecystectomy, or in Crohn’s disease). The SeHCAT test is the gold standard for diagnosis, but empiric response to bile acid sequestrants (cholestyramine, colesevelam) is often used as a therapeutic trial. This diagnosis should be considered in any patient with chronic watery diarrhea, especially if worse after fatty meals or cholecystectomy.
3. History Taking
A comprehensive approach to eliciting the Diarrhea history
Red Flags — Require Urgent Evaluation
- Bloody diarrhea (dysentery) — Invasive infection, inflammatory bowel disease, ischemic colitis
- Severe dehydration signs — Altered mental status, oliguria, hypotension, tachycardia
- High fever (>38.5°C / 101.3°F) — Invasive bacterial infection, toxic megacolon
- Severe abdominal pain out of proportion — Ischemic bowel, perforation, toxic megacolon
- Recent hospitalization or antibiotic use — Clostridioides difficile infection
- Immunocompromised state — Opportunistic infections, severe or prolonged course
- Age >70 years with acute diarrhea — Higher risk of complications and dehydration
- Nocturnal diarrhea waking from sleep — Organic pathology (not functional)
- Unintentional weight loss >5% — Malignancy, malabsorption, inflammatory bowel disease
- Signs of hemolytic uremic syndrome — Pallor, petechiae, decreased urine output following bloody diarrhea
Systematic History: The “DIARRHEA” Approach
Use the mnemonic “DIARRHEA” to ensure comprehensive history taking:
- D — Duration and onset: When did it start? Sudden or gradual? Acute (<14 days), persistent (14-28 days), or chronic (>28 days)?
- I — Infection risk factors: Recent travel? Sick contacts? Contaminated food or water exposure? Daycare or institutional exposure?
- A — Appearance of stool: Watery, bloody, mucoid, greasy, or explosive? Volume and frequency?
- R — Related symptoms: Fever, nausea, vomiting, abdominal pain, tenesmus, urgency, incontinence?
- R — Recent medications and antibiotics: Any new medications? Antibiotics in past 3 months? Laxatives, antacids, supplements?
- H — History (medical and surgical): Diabetes, thyroid disease, immunocompromise, inflammatory bowel disease, celiac disease? Prior abdominal surgery?
- E — Eating patterns and diet: Lactose, fructose, sorbitol, gluten intake? Artificial sweeteners? Alcohol? Dietary changes?
- A — Alarm features and impact: Weight loss, night sweats, blood in stool? Impact on daily life, sleep, work?
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Viral gastroenteritis | Acute onset, watery, vomiting prominent, sick contacts, self-limiting | “Has anyone else around you been sick with similar symptoms in the past few days?” |
| Bacterial food poisoning | Abrupt onset 6-72 hours after suspect meal, may be bloody | “Can you think of any food you ate in the last 1-3 days that tasted off or that others who ate it also got sick?” |
| Clostridioides difficile infection | Recent antibiotics, hospitalization, foul-smelling watery stool | “Have you taken any antibiotics in the past 3 months, even a short course?” |
| Traveler’s diarrhea | Onset during or shortly after travel to endemic area | “Have you traveled anywhere in the past few weeks, especially to developing countries?” |
| Lactose intolerance | Bloating, gas, diarrhea after dairy; resolves with avoidance | “Do you notice that your symptoms are worse after consuming milk, ice cream, or cheese?” |
| Celiac disease | Chronic diarrhea, bloating, weight loss, fatigue, anemia | “Do your symptoms seem related to eating bread, pasta, or other wheat-containing foods?” |
| Inflammatory bowel disease | Bloody diarrhea, abdominal pain, weight loss, extraintestinal manifestations | “Have you noticed blood or mucus in your stool? Any joint pains, skin rashes, or mouth ulcers?” |
| Irritable bowel syndrome (diarrhea-predominant) | Chronic, crampy pain relieved by defecation, no nocturnal symptoms, no weight loss | “Is your abdominal pain or discomfort relieved after you have a bowel movement?” |
| Bile acid malabsorption | Watery diarrhea, worse after fatty meals, post-cholecystectomy | “Have you had your gallbladder removed? Is the diarrhea worse after eating fatty or greasy foods?” |
| Microscopic colitis | Chronic watery diarrhea in older adults, often on multiple medications | “Have you started any new medications in the past few months, particularly NSAIDs or proton pump inhibitors?” |
| Hyperthyroidism | Diarrhea with weight loss despite good appetite, heat intolerance, tremor | “Have you noticed any weight loss despite eating well, feeling hot when others are comfortable, or trembling of your hands?” |
| Colorectal malignancy | Change in bowel habit in older adult, blood in stool, weight loss, anemia | “Have you noticed a recent change in your bowel pattern that is different from your normal? Any blood in the stool?” |
| Chronic pancreatitis / Pancreatic insufficiency | Steatorrhea, epigastric pain radiating to back, history of alcohol use | “Are your stools pale, bulky, foul-smelling, or oily? Do they float and are difficult to flush?” |
| Factitious diarrhea / Laxative abuse | Often healthcare workers, eating disorders, inconsistent history | “Are you taking anything to help with constipation or weight loss, including herbal products or teas?” |
Exposure History for Infectious Causes
| Exposure Type | Associated Pathogens | Key Questions |
|---|---|---|
| Undercooked poultry | Salmonella, Campylobacter | “Have you eaten any chicken or turkey that may have been undercooked or pink inside?” |
| Undercooked ground beef | Escherichia coli O157:H7 | “Have you eaten any hamburgers or ground beef that was rare or medium-rare?” |
| Raw eggs or egg products | Salmonella | “Have you eaten any foods containing raw or undercooked eggs, like homemade mayonnaise, Caesar dressing, or cookie dough?” |
| Raw seafood or shellfish | Vibrio species, Norovirus, Hepatitis A | “Have you eaten any raw oysters, sushi, or other raw seafood recently?” |
| Unpasteurized dairy | Listeria, Salmonella, Campylobacter, E. coli | “Do you consume any raw or unpasteurized milk, cheese, or dairy products?” |
| Contaminated water | Giardia, Cryptosporidium, Vibrio cholerae | “Have you been camping or hiking and drunk water from streams or lakes? Any swimming in natural water?” |
| Daycare or institutional exposure | Rotavirus, Norovirus, Giardia, Shigella | “Do you work in or have children in daycare? Any nursing home or institutional contact?” |
| Farm animal contact | E. coli O157:H7, Cryptosporidium, Salmonella | “Have you visited a farm, petting zoo, or had contact with farm animals recently?” |
| Pet reptile or amphibian | Salmonella | “Do you have any pet turtles, snakes, lizards, or frogs at home?” |
Medication and Dietary History
Medications That Commonly Cause Diarrhea
- Antibiotics — All classes; disruption of gut microbiome; Clostridioides difficile risk
- Proton pump inhibitors — Altered gut pH affects microbiome; increased C. difficile and other infection risk
- NSAIDs — Direct mucosal injury; associated with microscopic colitis
- Metformin — Very common (up to 50% of patients); dose-dependent; may improve with time
- Colchicine — Dose-dependent; often indicates toxicity at high levels
- Magnesium-containing antacids — Osmotic diarrhea
- Selective serotonin reuptake inhibitors (SSRIs) — Increased intestinal motility
- Chemotherapy agents — Mucosal damage (mucositis)
- Immunosuppressants — Mycophenolate, tacrolimus
- Orlistat (weight loss medication) — Fat malabsorption by design
- ACE inhibitors — Rare cause, often overlooked
- Laxatives — Including herbal preparations and “detox” teas
Dietary Causes to Explore
- Lactose — Milk, ice cream, soft cheeses (lactose intolerance)
- Fructose — Fruit juices, honey, high-fructose corn syrup (malabsorption)
- Sorbitol and sugar alcohols — Sugar-free candies, gums, diabetic products
- Gluten — Wheat, barley, rye (celiac disease, non-celiac gluten sensitivity)
- FODMAPs — Fermentable carbohydrates in many fruits, vegetables, legumes
- Caffeine — Stimulates colonic motility; high intake can cause diarrhea
- Alcohol — Direct mucosal irritant; accelerates transit; chronic use affects absorption
- Fiber supplements — Excessive intake or rapid introduction
- Fatty foods — May worsen bile acid diarrhea
Social and Occupational History
- Occupation: Food handlers, healthcare workers, daycare workers (infectious risk)
- Travel: Endemic areas for specific pathogens
- Sexual history: Men who have sex with men at higher risk for certain infections (Shigella, Giardia, sexually transmitted proctitis)
- HIV risk factors: Opportunistic infections if immunocompromised
Clinical Pearl: The “Fasting Test” Question
Ask the patient: “Does your diarrhea stop or significantly improve when you don’t eat for a day?”
- Yes (improves with fasting): Suggests osmotic diarrhea — unabsorbed dietary substance is the cause (lactose intolerance, sorbitol, magnesium)
- No (continues despite fasting): Suggests secretory diarrhea — the bowel is actively secreting regardless of intake (infection, hormone-secreting tumor, bile acid malabsorption)
This simple question can help differentiate the mechanism before any testing is done.
4. Physical Examination
A systematic head-to-toe approach for Diarrhea
Systematic Framework: Use the “Head to Extremities” approach for complete examination of patients presenting with diarrhea. The primary goals are to: (1) assess hydration status, (2) identify signs of serious underlying disease, and (3) look for clues to the etiology.
General Inspection
- Appearance: Well or unwell? Alert or lethargic? Cachectic (suggesting malignancy or malabsorption)?
- Hydration status: Dry mucous membranes, sunken eyes, reduced skin turgor, delayed capillary refill
- Nutritional status: Signs of weight loss, muscle wasting, temporal wasting
- Pallor: May indicate anemia from blood loss, malabsorption (iron, B12, folate), or chronic disease
- Skin findings: Jaundice (liver disease, hemolysis), rashes (celiac dermatitis herpetiformis, inflammatory bowel disease-associated pyoderma gangrenosum or erythema nodosum)
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Temperature | Fever >38°C (100.4°F) | Suggests invasive bacterial infection, inflammatory bowel disease flare, intra-abdominal abscess |
| Heart Rate | Tachycardia (>100 bpm) | Dehydration, sepsis, hyperthyroidism; orthostatic increase suggests volume depletion |
| Blood Pressure | Hypotension (<90/60 mmHg) or orthostatic drop (>20 mmHg systolic on standing) | Significant dehydration, sepsis, adrenal insufficiency; check orthostatic vitals |
| Respiratory Rate | Tachypnea | Metabolic acidosis compensation (severe dehydration, sepsis); Kussmaul breathing if severe |
| Weight | Acute loss (fluid) vs. chronic loss (disease) | Rapid weight loss suggests dehydration; chronic loss suggests malabsorption, malignancy, or inflammatory disease |
Assessing Dehydration Severity
| Finding | Mild Dehydration (3-5%) | Moderate Dehydration (6-9%) | Severe Dehydration (≥10%) |
|---|---|---|---|
| Mental status | Normal, alert | Restless, irritable | Lethargic, obtunded |
| Thirst | Slightly increased | Moderately increased | Drinks poorly or unable to drink |
| Heart rate | Normal | Increased | Very increased, weak pulse |
| Blood pressure | Normal | Normal to low, orthostatic | Low, may be undetectable |
| Mucous membranes | Slightly dry | Dry | Very dry, parched |
| Skin turgor | Normal | Reduced (recoil 1-2 seconds) | Very reduced (recoil >2 seconds) |
| Eyes | Normal | Slightly sunken | Deeply sunken |
| Urine output | Slightly decreased | Decreased, dark | Minimal or absent |
| Capillary refill | Normal (<2 seconds) | Delayed (2-3 seconds) | Very delayed (>3 seconds) |
Head and Neck Examination
Mouth and Oral Cavity
- Mucous membranes: Dry, tacky (dehydration)
- Tongue: Dry, fissured (dehydration); glossitis (B12, folate, iron deficiency)
- Angular cheilitis: Iron, B vitamin deficiency (malabsorption)
- Aphthous ulcers: Crohn’s disease, celiac disease
- Oral thrush: Immunocompromise, recent antibiotics
Eyes and Neck
- Eyes: Sunken (dehydration); pale conjunctivae (anemia); episcleritis, uveitis (inflammatory bowel disease)
- Thyroid: Goiter, nodules, tenderness (hyperthyroidism as cause of diarrhea)
- Lymphadenopathy: Infection, malignancy, HIV
- Jugular venous pressure: Low (hypovolemia); elevated (consider right heart failure as alternative cause of GI symptoms)
Abdominal Examination
Inspection
- Distension: Gaseous distension (obstruction, ileus, bacterial overgrowth); ascites (liver disease, malignancy)
- Scars: Prior surgeries (short bowel, adhesions, blind loop syndrome)
- Visible peristalsis: Obstruction
- Skin changes: Caput medusae (portal hypertension); striae (Cushing’s syndrome)
- Fistula openings: Crohn’s disease
Auscultation
- Hyperactive bowel sounds: Increased motility, early obstruction, gastroenteritis
- High-pitched “tinkling” sounds: Obstruction
- Absent bowel sounds: Ileus, peritonitis (concerning finding)
- Borborygmi: Loud gurgling — common in functional disorders and malabsorption
Palpation
- Tenderness location: Right lower quadrant (Crohn’s disease, appendicitis); left lower quadrant (diverticulitis, inflammatory bowel disease); epigastric (peptic disease, pancreatitis)
- Rebound tenderness or guarding: Peritoneal inflammation — requires urgent evaluation
- Masses: Inflammatory mass (Crohn’s), malignancy, abscess
- Hepatomegaly: Metastatic disease, fatty liver, congestive hepatopathy
- Splenomegaly: Portal hypertension, infection, hematologic malignancy
Percussion
- Tympany: Gaseous distension
- Dullness: Ascites (shifting dullness), masses, organomegaly
- Tenderness to percussion: Peritoneal irritation
Rectal Examination
When to Perform Rectal Examination
Consider digital rectal examination when there is:
- Bloody diarrhea (to assess for masses, fissures, hemorrhoids)
- Suspicion of inflammatory bowel disease or malignancy
- Need to assess stool character (especially in elderly or obtunded patients)
- Concern for fecal impaction with overflow diarrhea
Assess: Sphincter tone, masses, tenderness, stool character (mucus, blood), fissures, fistulae, perianal skin changes
Perianal Inspection
- Skin excoriation: Severe or prolonged diarrhea
- Fissures: Crohn’s disease, chronic constipation with overflow
- Fistula openings: Crohn’s disease
- Skin tags: Crohn’s disease (may be edematous and painful)
- Hemorrhoids: Common; may bleed
- Ulceration: Herpes simplex, syphilis, inflammatory bowel disease
Extraintestinal Findings (Clues to Underlying Disease)
| System | Finding | Associated Condition |
|---|---|---|
| Skin | Dermatitis herpetiformis (itchy, blistering rash on elbows, knees, buttocks) | Celiac disease |
| Skin | Erythema nodosum (painful red nodules on shins) | Inflammatory bowel disease (especially Crohn’s) |
| Skin | Pyoderma gangrenosum (painful ulcers with undermined edges) | Inflammatory bowel disease (especially ulcerative colitis) |
| Skin | Flushing episodes | Carcinoid syndrome |
| Skin | Necrolytic migratory erythema | Glucagonoma |
| Joints | Peripheral arthritis (large joints) | Inflammatory bowel disease, Whipple’s disease |
| Joints | Sacroiliitis, ankylosing spondylitis | Inflammatory bowel disease |
| Eyes | Episcleritis, uveitis | Inflammatory bowel disease |
| Hands | Clubbing | Inflammatory bowel disease, celiac disease (rare), malignancy |
| Hands | Koilonychia (spoon nails) | Iron deficiency (malabsorption) |
| Neurological | Peripheral neuropathy, ataxia | B12 deficiency (pernicious anemia, ileal disease, bacterial overgrowth) |
| Neurological | Tetany | Hypocalcemia from vitamin D or calcium malabsorption |
Expected Findings by Etiology
| Condition | General / Vitals | Abdominal | Other Findings |
|---|---|---|---|
| Viral gastroenteritis | Variable dehydration, low-grade fever | Diffuse mild tenderness, hyperactive bowel sounds | Usually unremarkable |
| Bacterial dysentery | Fever, tachycardia, dehydration | Lower abdominal tenderness, bloody stool on rectal exam | May appear toxic if severe |
| Clostridioides difficile infection | Fever, may be severely ill | Diffuse tenderness, distension if severe; watch for toxic megacolon | Recent hospitalization/antibiotics history |
| Inflammatory bowel disease | May have weight loss, pallor | Right lower quadrant mass/tenderness (Crohn’s); left-sided tenderness (ulcerative colitis) | Extraintestinal: arthritis, eye findings, skin lesions, perianal disease (Crohn’s) |
| Celiac disease | Pallor, weight loss, short stature | Often unremarkable; mild distension | Dermatitis herpetiformis, glossitis, angular cheilitis, osteoporosis |
| Irritable bowel syndrome | Normal vitals, no weight loss | Mild diffuse tenderness; palpable sigmoid (stool) | Normal examination is expected |
| Hyperthyroidism | Tachycardia, warm skin, tremor, weight loss | Usually unremarkable | Goiter, lid lag, proptosis (Graves’), hyperreflexia |
| Carcinoid syndrome | Flushing, wheezing | Hepatomegaly (if metastatic) | Right-sided heart murmurs (carcinoid heart disease) |
| Colorectal malignancy | Cachexia, pallor, weight loss | Palpable mass, hepatomegaly (metastases) | Lymphadenopathy, rectal mass on digital examination |
Important Teaching Point
Normal examination is common! Many causes of diarrhea present with entirely normal physical examination findings, including:
- Irritable bowel syndrome (diarrhea-predominant)
- Lactose intolerance and other carbohydrate malabsorption
- Bile acid malabsorption
- Microscopic colitis
- Early celiac disease
- Medication-induced diarrhea
- Mild viral gastroenteritis
A normal examination does not exclude significant pathology. The history often provides more diagnostic clues than the physical examination in patients with diarrhea. However, the examination is essential for assessing hydration status and identifying red flag findings that require urgent action.
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
Acute Diarrhea (Duration: Less than 14 days)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 80%) | Viral gastroenteritis (Norovirus, Rotavirus, Adenovirus) | Watery diarrhea, nausea, vomiting, low-grade fever, sick contacts, self-limiting in 1-3 days | Severe dehydration in elderly or immunocompromised |
| Bacterial food poisoning (Staphylococcus aureus, Bacillus cereus toxins) | Rapid onset (1-6 hours), prominent vomiting, resolves within 24 hours, others with same meal affected | Rarely severe; supportive care usually sufficient | |
| Medication-induced diarrhea | Temporal relationship with new medication; common culprits: antibiotics, metformin, NSAIDs, PPIs | Consider Clostridioides difficile if on antibiotics | |
| Dietary indiscretion | Excess alcohol, caffeine, sorbitol (sugar-free products), high-fat meal | None typically | |
| LESS COMMON (approximately 15%) | Bacterial enteritis (Salmonella, Campylobacter, Shigella) | Fever, bloody or mucoid stool, abdominal cramps, food exposure history | High fever, bloody diarrhea, severe dehydration |
| Clostridioides difficile infection | Recent antibiotics (within 3 months), hospitalization, foul-smelling watery stool, abdominal pain | Toxic megacolon, severe leukocytosis, hypotension | |
| Traveler’s diarrhea (Enterotoxigenic E. coli most common) | Travel to endemic area within past 2 weeks, watery diarrhea, cramps | Bloody stool, prolonged duration suggests invasive pathogen | |
| Parasitic infection (Giardia, Cryptosporidium) | Camping/hiking history, contaminated water, bloating, foul-smelling stool, may be prolonged | Prolonged diarrhea in immunocompromised (Cryptosporidium) | |
| UNCOMMON BUT SERIOUS (approximately 5%) | Escherichia coli O157:H7 | Bloody diarrhea without fever (initially), undercooked beef exposure | Hemolytic uremic syndrome (pallor, oliguria, petechiae) — avoid antibiotics |
| Ischemic colitis | Elderly, cardiovascular disease, sudden crampy left-sided pain, bloody diarrhea | Severe pain, peritoneal signs, hemodynamic instability | |
| Initial presentation of inflammatory bowel disease | Bloody diarrhea, weight loss, may have extraintestinal manifestations | Toxic megacolon, severe bleeding, systemic toxicity | |
| Acute HIV infection | Diarrhea with fever, rash, lymphadenopathy, pharyngitis; recent high-risk exposure | High viral load, may be highly infectious |
Chronic Diarrhea (Duration: Greater than 4 weeks)
Step-by-Step Approach to Chronic Diarrhea:
- Step 1: Rule out obvious causes — Is the patient taking medications that cause diarrhea? Is there excess caffeine, alcohol, or artificial sweetener intake? Is there lactose intolerance?
- Step 2: Classify by stool type — Watery (secretory vs. osmotic), inflammatory (blood/mucus), or fatty (steatorrhea)?
- Step 3: Consider the “Big Four” causes — Irritable bowel syndrome-diarrhea predominant, inflammatory bowel disease, malabsorption syndromes (celiac, pancreatic insufficiency), and microscopic colitis account for the majority of chronic diarrhea cases
- Step 4: Investigate for less common causes if initial workup is negative
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Irritable bowel syndrome (diarrhea-predominant) | 20-25% | Chronic, crampy abdominal pain relieved by defecation, no nocturnal symptoms, no weight loss, often alternates with constipation, bloating common |
| Bile acid malabsorption | 10-15% (underdiagnosed) | Watery diarrhea, worse after fatty meals, history of cholecystectomy or ileal disease, responds to bile acid sequestrants | |
| Lactose intolerance | 10-15% | Bloating, gas, diarrhea after dairy intake; improves with lactose avoidance | |
| Medication-induced | 10% | Temporal relationship; metformin, SSRIs, colchicine, magnesium supplements common causes | |
| Microscopic colitis (lymphocytic or collagenous) | 5-10% | Older adults (especially women), watery non-bloody diarrhea, often on NSAIDs or PPIs, normal colonoscopy appearance (biopsy required) | |
| LESS COMMON | Celiac disease | 5% | Bloating, steatorrhea, weight loss, iron deficiency anemia, family history, dermatitis herpetiformis |
| Inflammatory bowel disease (Crohn’s disease, ulcerative colitis) | 5% | Bloody diarrhea (especially ulcerative colitis), abdominal pain, weight loss, extraintestinal manifestations, perianal disease (Crohn’s) | |
| Chronic infections (Giardia, Clostridioides difficile) | 3-5% | Giardia: bloating, foul stools, camping/travel history; C. difficile: recurrent symptoms after treatment | |
| Small intestinal bacterial overgrowth | 3-5% | Bloating, gas, steatorrhea, often with predisposing factors (diabetes, prior surgery, motility disorders) | |
| Post-cholecystectomy diarrhea | 3-5% | Onset after gallbladder removal, watery diarrhea, responds to bile acid sequestrants | |
| UNCOMMON BUT IMPORTANT | Colorectal carcinoma | 1-2% | Age >50, change in bowel habit, blood in stool, weight loss, iron deficiency anemia, family history |
| Chronic pancreatitis / Pancreatic insufficiency | 1-2% | Steatorrhea, epigastric pain radiating to back, history of alcohol abuse or recurrent pancreatitis | |
| Hyperthyroidism | 1% | Weight loss despite good appetite, heat intolerance, tremor, tachycardia, anxiety | |
| Diabetic autonomic neuropathy | 1% | Long-standing diabetes, nocturnal diarrhea, alternating constipation, other autonomic symptoms | |
| Carcinoid syndrome | <1% | Flushing, wheezing, diarrhea; usually with hepatic metastases | |
| Factitious diarrhea / Laxative abuse | 1-2% | Healthcare workers, eating disorders, inconsistent history, hypokalemia, melanosis coli |
Mechanistic Approach to Chronic Diarrhea
Watery — Secretory
Bile acid malabsorption
Microscopic colitis
Carcinoid syndrome
VIPoma
Medullary thyroid carcinoma
Chronic mesenteric ischemia
Watery — Osmotic
Lactose intolerance
Fructose malabsorption
Sorbitol / sugar alcohols
Magnesium-containing antacids
Laxative abuse (osmotic agents)
Celiac disease (early)
Inflammatory
Ulcerative colitis
Crohn’s disease
Chronic infections
Ischemic colitis
Radiation colitis
Colorectal malignancy
Fatty (Steatorrhea)
Celiac disease
Chronic pancreatitis
Small intestinal bacterial overgrowth
Short bowel syndrome
Whipple’s disease
Giardiasis
Drug-Induced Diarrhea
| Drug or Drug Class | Mechanism | Characteristics | Time to Resolution After Stopping |
|---|---|---|---|
| Antibiotics (all classes) | Gut microbiome disruption; may lead to C. difficile overgrowth | Onset during or shortly after course; watery; consider C. difficile if severe | Days to weeks; C. difficile may require treatment |
| Metformin | Increased intestinal glucose utilization, bile acid alterations, gut microbiome changes | Dose-dependent; affects up to 50% of patients; often improves with time | Days to weeks; consider extended-release formulation |
| Proton pump inhibitors | Altered gut pH affects microbiome; increased infection susceptibility; associated with microscopic colitis | May develop after months of use; watery diarrhea | Weeks to months |
| NSAIDs | Direct mucosal injury; strongly associated with microscopic colitis | May be delayed onset; watery; consider colonoscopy with biopsies | Weeks to months (if microscopic colitis, may need treatment) |
| Selective serotonin reuptake inhibitors (SSRIs) | Increased intestinal serotonin; accelerated motility | Common early in treatment; may persist | Days to weeks |
| Colchicine | Inhibits microtubule function; affects enterocyte turnover | Dose-dependent; often indicates toxicity at high doses | Days |
| Magnesium-containing antacids/supplements | Osmotic effect; poorly absorbed magnesium draws water into lumen | Dose-dependent; osmotic diarrhea | Days |
| Orlistat | Lipase inhibition causes fat malabsorption (intended effect) | Steatorrhea, oily spotting, fecal urgency; worse with high-fat meals | Days after stopping |
| Mycophenolate mofetil | Direct GI toxicity; may cause colitis | Dose-dependent; may mimic inflammatory bowel disease | Days to weeks; may need dose reduction |
| Olmesartan | Sprue-like enteropathy (villous atrophy) | Severe chronic diarrhea, weight loss; may mimic celiac disease but serology negative | Weeks to months; histological recovery may take longer |
| Immune checkpoint inhibitors | Immune-mediated colitis | May be severe; bloody diarrhea; requires prompt recognition | Variable; may require immunosuppression |
| Chemotherapy agents | Mucosal damage (mucositis); various mechanisms by agent | Common; timing varies by agent; may be severe | Days to weeks after cycle completion |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Recent antibiotics + watery diarrhea | Clostridioides difficile infection | Stool C. difficile toxin assay; stop inciting antibiotic |
| Bloody diarrhea + fever | Invasive bacterial infection (Shigella, Salmonella, Campylobacter) | Stool culture; supportive care; antibiotics if severe |
| Bloody diarrhea + NO fever + undercooked beef | E. coli O157:H7 | Stool culture for O157; monitor for hemolytic uremic syndrome; avoid antibiotics |
| Chronic diarrhea + weight loss + iron deficiency | Celiac disease or colorectal malignancy | Tissue transglutaminase IgA; colonoscopy if age >45 or red flags |
| Chronic watery diarrhea + older woman + NSAIDs/PPIs | Microscopic colitis | Colonoscopy with random biopsies (appears normal grossly) |
| Diarrhea worse after fatty meals + post-cholecystectomy | Bile acid malabsorption | Empiric trial of bile acid sequestrant (cholestyramine) |
| Bloating + foul stools + camping/travel history | Giardiasis | Stool antigen test; empiric metronidazole if high suspicion |
| Chronic diarrhea + abdominal pain relieved by defecation + NO red flags | Irritable bowel syndrome (diarrhea-predominant) | Rome IV criteria; limited workup; trial of dietary modification |
| Steatorrhea + epigastric pain + alcohol history | Chronic pancreatitis with exocrine insufficiency | Fecal elastase; CT/MRCP for pancreatic changes |
| Diarrhea + flushing + wheezing | Carcinoid syndrome | 24-hour urine 5-HIAA; CT for tumor localization |
| Diarrhea + weight loss + heat intolerance + tremor | Hyperthyroidism | TSH, free T4 |
| Nocturnal diarrhea + long-standing diabetes | Diabetic autonomic neuropathy / bacterial overgrowth | Glucose breath test; empiric rifaximin trial |
| Bloody diarrhea + extraintestinal symptoms (arthritis, eye inflammation, skin lesions) | Inflammatory bowel disease | Colonoscopy with biopsies; fecal calprotectin |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
When to Investigate Acute Diarrhea
Most acute diarrhea is self-limiting and does not require investigation. Consider testing when:
- Bloody diarrhea or dysentery
- Fever >38.5°C (101.3°F)
- Severe dehydration requiring IV fluids
- Duration >7 days without improvement
- Immunocompromised patient
- Recent hospitalization or antibiotic use (C. difficile risk)
- Concern for outbreak or public health implications (food handlers)
- Recent travel to endemic areas
Baseline Investigations for Acute Diarrhea (When Indicated)
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Complete blood count | Assess for infection, anemia, dehydration | Leukocytosis (infection); elevated hemoglobin (hemoconcentration); thrombocytopenia (hemolytic uremic syndrome) | WBC >15,000 with bandemia suggests severe infection; platelets dropping may herald HUS |
| Basic metabolic panel | Assess dehydration, electrolyte disturbances | Elevated BUN/creatinine ratio (prerenal); hypokalemia, hyponatremia, metabolic acidosis | BUN:creatinine ratio >20:1 suggests dehydration |
| Stool studies for pathogens | Identify causative organism | Bacterial culture, ova and parasites, Clostridioides difficile toxin | Multiplex PCR panels increasingly used; higher sensitivity but may detect colonization |
| Fecal leukocytes or lactoferrin | Distinguish inflammatory from non-inflammatory diarrhea | Presence suggests invasive/inflammatory process | Lactoferrin more sensitive than leukocyte microscopy |
Stool Testing: What to Order and When
| Test | Indication | Pathogens Detected | Notes |
|---|---|---|---|
| Stool culture | Bloody diarrhea, severe illness, outbreak investigation | Salmonella, Shigella, Campylobacter, E. coli O157:H7 | Specify request for O157:H7; takes 48-72 hours |
| Clostridioides difficile testing | Recent antibiotics, hospitalization, healthcare exposure | C. difficile toxins A and B | Preferred: GDH + toxin EIA, or NAAT; do not test formed stool; do not repeat if negative |
| Ova and parasites (O&P) examination | Prolonged diarrhea (>14 days), travel, camping, immunocompromised | Giardia, Cryptosporidium, Entamoeba, Cyclospora | Three samples increase sensitivity; stool antigen tests for Giardia and Cryptosporidium are more sensitive |
| Multiplex PCR panel (GI pathogen panel) | Severe or prolonged diarrhea when rapid diagnosis needed | Multiple bacteria, viruses, parasites simultaneously | Rapid results (hours); expensive; may detect asymptomatic carriage |
| Giardia antigen | Chronic diarrhea, bloating, travel/camping history | Giardia lamblia | More sensitive than O&P microscopy |
Baseline Investigations for Chronic Diarrhea
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Complete blood count | Screen for anemia, inflammation | Microcytic anemia (iron deficiency — celiac, malignancy); macrocytic anemia (B12/folate — malabsorption) | MCV helps classify anemia cause |
| Comprehensive metabolic panel | Assess electrolytes, renal/liver function, albumin | Hypokalemia, hypoalbuminemia (protein-losing enteropathy or malabsorption) | Low albumin suggests chronic malabsorption or inflammation |
| C-reactive protein (CRP) and/or ESR | Screen for inflammatory process | Elevation suggests inflammatory bowel disease, infection, or malignancy | Normal does not exclude disease; CRP more specific |
| Thyroid-stimulating hormone (TSH) | Screen for hyperthyroidism | Low TSH with elevated free T4 (hyperthyroidism) | Often overlooked cause; easy to screen |
| Tissue transglutaminase IgA (tTG-IgA) | Screen for celiac disease | Elevation strongly suggests celiac disease | Check total IgA simultaneously (2-3% of celiac patients are IgA deficient, causing false-negative tTG-IgA) |
| Fecal calprotectin | Distinguish inflammatory from functional diarrhea | >50 μg/g suggests inflammation; >250 μg/g highly suggestive of inflammatory bowel disease | Excellent negative predictive value; if normal, inflammatory bowel disease very unlikely |
| Stool ova and parasites / Giardia antigen | Rule out chronic parasitic infection | Giardia most common chronic parasitic cause | Consider especially with travel history, bloating, camping exposure |
Targeted Investigations by Suspected Etiology
If Suspecting Inflammatory Bowel Disease
First-Line Tests
- Fecal calprotectin: >250 μg/g highly suggestive; useful for monitoring
- CRP: Often elevated in active disease
- Complete blood count: Anemia, thrombocytosis common
- Albumin: May be low in severe disease
Definitive Tests
- Colonoscopy with biopsies: Gold standard for diagnosis; assess extent and severity
- Upper endoscopy: If Crohn’s disease suspected (may have upper GI involvement)
- CT or MR enterography: Evaluate small bowel (Crohn’s disease)
- Capsule endoscopy: Small bowel visualization if CT/MR inconclusive
If Suspecting Celiac Disease
First-Line Tests
- Tissue transglutaminase IgA (tTG-IgA): Sensitivity 93%, specificity 98%
- Total IgA: Order simultaneously to exclude IgA deficiency
- If IgA deficient: Order deamidated gliadin peptide IgG (DGP-IgG)
Confirmatory Tests
- Upper endoscopy with duodenal biopsies: Gold standard; must be on gluten-containing diet at time of biopsy
- Histology: Villous atrophy, crypt hyperplasia, increased intraepithelial lymphocytes (Marsh classification)
- HLA-DQ2/DQ8 testing: Useful for exclusion (>99% of celiac patients carry these); negative result essentially rules out celiac
If Suspecting Malabsorption / Steatorrhea
First-Line Tests
- Fecal elastase-1: <200 μg/g suggests pancreatic insufficiency; <100 μg/g = severe insufficiency
- Serum vitamin levels: B12, folate, iron, vitamin D, vitamin A
- INR/PT: Prolonged suggests vitamin K malabsorption
- Calcium: May be low with vitamin D malabsorption
Second-Line Tests
- 72-hour fecal fat collection: Gold standard for steatorrhea; >7 g/day is abnormal (rarely done due to difficulty)
- CT or MRCP: Evaluate for chronic pancreatitis (calcifications, ductal changes)
- Secretin-stimulated MRCP: Evaluates pancreatic exocrine function
If Suspecting Small Intestinal Bacterial Overgrowth (SIBO)
First-Line Tests
- Glucose or lactulose hydrogen breath test: Rise in hydrogen >20 ppm above baseline within 90 minutes suggests SIBO
- Methane measurement: Some patients produce methane instead of hydrogen
Alternative Approach
- Empiric antibiotic trial: Rifaximin 550 mg three times daily for 14 days — response supports diagnosis
- Small bowel aspirate and culture: Gold standard but invasive; rarely performed; >105 CFU/mL is diagnostic
If Suspecting Bile Acid Malabsorption
Diagnostic Tests
- SeHCAT test: Gold standard (retention <15% at 7 days is abnormal); not widely available in all countries
- Serum 7α-hydroxy-4-cholesten-3-one (C4): Elevated in bile acid malabsorption; increasingly available
- Fecal bile acids: Elevated; limited availability
Practical Approach
- Empiric trial of bile acid sequestrant: Most practical approach; cholestyramine 4 g once to three times daily or colesevelam
- Response within 2-3 days supports diagnosis
- Consider especially: Post-cholecystectomy, ileal resection, Crohn’s disease, idiopathic
If Suspecting Microscopic Colitis
Diagnostic Approach
- Colonoscopy: Appears grossly normal
- Random biopsies from multiple segments: Essential — diagnosis is histological
Histological Findings
- Lymphocytic colitis: >20 intraepithelial lymphocytes per 100 epithelial cells
- Collagenous colitis: Thickened subepithelial collagen band (>10 μm)
Empiric Treatment Trials as Diagnostic Tools
Sequential Empiric Therapy Approach for Chronic Diarrhea
When diagnosis is unclear after initial workup, empiric treatment trials can serve as valuable diagnostic tools. Response to therapy supports the diagnosis.
- Lactose elimination trial: Strict lactose avoidance for 2 weeks — improvement supports lactose intolerance
- Bile acid sequestrant trial: Cholestyramine 4 g daily to three times daily for 1-2 weeks — improvement supports bile acid malabsorption
- Antibiotic trial for SIBO: Rifaximin 550 mg three times daily for 14 days — improvement supports small intestinal bacterial overgrowth
- Low-FODMAP diet trial: 4-6 week elimination — improvement supports carbohydrate malabsorption (IBS-D)
- Pancreatic enzyme supplementation: Trial with meals for 2-4 weeks — improvement supports pancreatic insufficiency
- Gluten-free diet trial: Only after celiac serology/biopsy completed — improvement may support non-celiac gluten sensitivity (if celiac excluded)
When to Refer for Endoscopy
| Indication | Procedure | Rationale |
|---|---|---|
| Chronic diarrhea with alarm features (blood, weight loss, anemia) | Colonoscopy with biopsies | Exclude inflammatory bowel disease, malignancy, microscopic colitis |
| Age ≥45-50 with new chronic diarrhea | Colonoscopy | Colorectal cancer screening indicated |
| Positive celiac serology | Upper endoscopy with duodenal biopsies | Confirm celiac disease diagnosis |
| Chronic watery diarrhea in older adult | Colonoscopy with random biopsies | Microscopic colitis (normal-appearing mucosa) |
| Suspected Crohn’s disease with negative colonoscopy | Upper endoscopy, capsule endoscopy, or CT/MR enterography | Evaluate small bowel involvement |
| Refractory or unexplained chronic diarrhea | Upper endoscopy with small bowel biopsies | Exclude small bowel pathology (Whipple’s, giardiasis, lymphoma) |
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Severe dehydration (altered mental status, hypotension, oliguria, unable to tolerate oral fluids) | EMERGENT | IV fluid resuscitation; hospital admission; electrolyte monitoring; identify cause |
| Bloody diarrhea with high fever (>38.5°C) and systemic toxicity | EMERGENT | IV fluids; stool cultures; blood cultures; empiric antibiotics if septic; consider hospitalization |
| Suspected toxic megacolon (severe abdominal distension, tenderness, fever, tachycardia in patient with colitis) | EMERGENT | Surgical consultation; abdominal X-ray/CT; NPO; IV antibiotics; possible colectomy |
| Hemolytic uremic syndrome suspected (bloody diarrhea followed by pallor, decreased urine, petechiae) | EMERGENT | Hospital admission; CBC, creatinine, LDH, peripheral smear; nephrology consultation; avoid antibiotics; supportive care |
| Moderate dehydration with inability to maintain oral intake | URGENT | IV or subcutaneous fluid rehydration; oral rehydration solution; close follow-up or observation |
| Bloody diarrhea without hemodynamic instability | URGENT | Stool studies; avoid antidiarrheals; hydration; assess for invasive infection vs. inflammatory bowel disease |
| Immunocompromised patient with acute diarrhea and fever | URGENT | Broad stool workup including opportunistic pathogens; low threshold for empiric treatment; infectious disease consultation |
| Clostridioides difficile infection with leukocytosis >15,000 or rising creatinine | URGENT | Oral vancomycin; consider fidaxomicin; surgical consultation if fulminant; stop inciting antibiotics |
| Acute watery diarrhea in otherwise healthy adult, mild-moderate symptoms | ROUTINE | Oral rehydration; dietary modification; symptomatic treatment; no investigation needed if <7 days |
| Chronic diarrhea without alarm features | ROUTINE | Outpatient workup; basic labs; consider empiric dietary trials; referral if needed |
Step 2: Classify by Duration
Acute (<14 days)
Most likely infectious or self-limiting
Proceed to Algorithm A
Focus: Hydration, red flags, identify severe cases
Persistent (14-28 days)
Consider protracted infection or post-infectious
Proceed to Algorithm B
Focus: Stool studies, C. difficile, parasites
Chronic (>28 days)
Systematic workup required
Proceed to Algorithm C
Focus: Classify mechanism, targeted investigation
Step 3: Follow the Appropriate Algorithm
Algorithm A: Acute Diarrhea (<14 days)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Watery diarrhea + vomiting + sick contacts + self-limiting | Viral gastroenteritis | Supportive care only; oral rehydration; no testing needed |
| Acute onset within 6 hours of suspect meal + prominent vomiting | Preformed toxin food poisoning (Staphylococcus, Bacillus) | Supportive care; resolves within 24 hours; no antibiotics |
| Bloody diarrhea + fever + abdominal cramps | Invasive bacterial infection | Stool culture; consider empiric fluoroquinolone or azithromycin if severe; hydration |
| Bloody diarrhea + NO fever + recent ground beef ingestion | Escherichia coli O157:H7 | Stool culture for O157:H7; NO antibiotics (increases HUS risk); monitor for HUS |
| Watery diarrhea + recent antibiotics or hospitalization | Clostridioides difficile infection | C. difficile testing; stop inciting antibiotic; oral vancomycin 125 mg four times daily |
| Traveler returned from developing country + watery diarrhea | Traveler’s diarrhea (enterotoxigenic E. coli most common) | Supportive care; azithromycin or fluoroquinolone if moderate-severe; consider Giardia if prolonged |
| Diarrhea started with new medication | Medication-induced diarrhea | Review medication list; consider stopping or substituting offending agent; rule out C. difficile if on antibiotics |
Algorithm B: Persistent Diarrhea (14-28 days)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Ongoing symptoms after treated bacterial gastroenteritis | Post-infectious irritable bowel syndrome | Reassurance; dietary modification; low-FODMAP trial; may take weeks to months to resolve |
| Bloating + foul stools + camping or travel history | Giardiasis | Giardia antigen test; treat with metronidazole 500 mg three times daily for 5-7 days or tinidazole single dose |
| Recurrent watery diarrhea after completed C. difficile treatment | Recurrent Clostridioides difficile infection | Extended vancomycin taper or fidaxomicin; consider fecal microbiota transplant for multiple recurrences |
| Immunocompromised + persistent watery diarrhea | Cryptosporidiosis or other opportunistic infection | Stool for Cryptosporidium, Cyclospora, microsporidium; optimize immune function; infectious disease consultation |
| Persistent symptoms + now developing bloody stool or weight loss | Possible inflammatory bowel disease unmasked by infection | Fecal calprotectin; colonoscopy with biopsies; gastroenterology referral |
Algorithm C: Chronic Diarrhea (>28 days)
Stepwise Approach to Chronic Diarrhea:
- Review medications — Stop or substitute any potentially causative drugs
- Basic laboratory workup — CBC, CMP, TSH, CRP, celiac serology (tTG-IgA + total IgA), fecal calprotectin
- Classify stool type — Watery, inflammatory, or fatty?
- Consider common treatable causes — Lactose intolerance, bile acid malabsorption, SIBO
- Endoscopy if indicated — Alarm features, age ≥45-50, positive calprotectin, failed empiric therapy
| Stool Type / Clinical Scenario | Consider These Diagnoses | Action |
|---|---|---|
| Watery + improves with fasting | Osmotic diarrhea (lactose, fructose, sorbitol, magnesium) | Dietary elimination trial; stool osmotic gap if uncertain |
| Watery + persists with fasting | Secretory diarrhea (bile acid malabsorption, microscopic colitis, neuroendocrine tumor) | Bile acid sequestrant trial; colonoscopy with biopsies; 24-hour urine 5-HIAA if flushing |
| Watery + post-cholecystectomy or ileal disease | Bile acid malabsorption | Empiric cholestyramine trial; response within days confirms diagnosis |
| Watery + older adult + NSAIDs or PPIs | Microscopic colitis | Colonoscopy with random biopsies; budesonide is first-line treatment |
| Bloody / mucoid + weight loss + elevated calprotectin | Inflammatory bowel disease | Colonoscopy with biopsies; gastroenterology referral |
| Fatty / steatorrhea + weight loss | Malabsorption (celiac, pancreatic insufficiency, SIBO) | Celiac serology; fecal elastase; consider upper endoscopy; hydrogen breath test for SIBO |
| Chronic + pain relieved by defecation + NO alarm features | Irritable bowel syndrome (diarrhea-predominant) | Rome IV criteria; limited workup to exclude organic disease; dietary and symptomatic treatment |
| Chronic + bloating + diabetes or prior surgery | Small intestinal bacterial overgrowth | Glucose hydrogen breath test; empiric rifaximin trial |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient cannot keep fluids down | Assess dehydration severity; consider IV fluids; antiemetics (ondansetron) | If unable to maintain hydration, admit or observe with IV rehydration |
| Patient asks for antidiarrheal medication | Assess for contraindications (bloody diarrhea, fever, suspected C. difficile or invasive infection) | If no contraindications, loperamide 4 mg initially then 2 mg after each loose stool (max 16 mg/day) |
| Patient on antibiotics develops diarrhea | Stop unnecessary antibiotics if possible; test for C. difficile | If C. difficile positive, treat with vancomycin or fidaxomicin; if negative, may be antibiotic-associated (non-C. diff) diarrhea |
| Diarrhea persists despite C. difficile treatment | Repeat C. difficile testing only if symptoms resolve then recur; consider alternative diagnoses | Extended vancomycin taper; fidaxomicin for recurrence; fecal microbiota transplant for multiple recurrences |
| Chronic diarrhea with normal initial workup | Review medications again; consider empiric trials (lactose-free, bile acid sequestrant) | Colonoscopy with biopsies (even if grossly normal — microscopic colitis); consider SIBO testing |
| Patient requests testing “for everything” | Explain stepwise approach; most acute diarrhea needs no testing | Target testing based on clinical presentation; avoid unnecessary multiplex panels in uncomplicated cases |
| Food handler with acute diarrhea | Exclude from work until symptom-free for 48 hours | Stool culture for Salmonella, Shigella, Campylobacter, E. coli O157:H7; follow local public health guidelines |
| Traveler with persistent diarrhea after return | Test for Giardia antigen; consider stool O&P × 3 | Empiric metronidazole or tinidazole for suspected giardiasis; tropical medicine referral if persistent |
| Diarrhea alternating with constipation | Consider irritable bowel syndrome (mixed type); rule out overflow diarrhea from impaction in elderly | Rome IV criteria for IBS; rectal examination in elderly; abdominal X-ray if obstruction suspected |
Troubleshooting Refractory Chronic Diarrhea
Ask These Questions When Diarrhea Persists Despite Workup
- Was the medication list thoroughly reviewed? — Many medications cause diarrhea; some are overlooked (supplements, herbal products, over-the-counter agents)
- Was bile acid malabsorption considered? — Often underdiagnosed; trial of bile acid sequestrant is low-risk and diagnostic
- Were colonoscopy biopsies obtained? — Microscopic colitis requires histology; grossly normal colonoscopy is not sufficient
- Was celiac serology performed correctly? — Ensure patient was on gluten-containing diet; check total IgA for deficiency
- Is the patient truly having diarrhea? — Confirm with stool diary; some patients interpret frequency or urgency without increased stool volume
- Is there fecal incontinence being described as diarrhea? — Different evaluation and management pathway
- Could there be multiple overlapping causes? — For example, bile acid malabsorption + lactose intolerance; address each component
- Has factitious diarrhea or laxative abuse been considered? — Especially if history inconsistent or unexplained hypokalemia
- Was small intestinal bacterial overgrowth evaluated? — Consider especially with diabetes, prior surgery, motility disorders
- Are rare causes being missed? — Carcinoid (24-hour urine 5-HIAA), VIPoma, mastocytosis, Addison’s disease
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
Most acute diarrhea needs no investigation: In immunocompetent adults without alarm features, acute watery diarrhea is usually viral and self-limiting within 3-5 days. Focus on hydration and symptomatic care.
Bile acid malabsorption is underdiagnosed: Up to 25-30% of patients labeled with “diarrhea-predominant irritable bowel syndrome” actually have bile acid malabsorption. Consider empiric cholestyramine trial in any chronic watery diarrhea, especially post-cholecystectomy.
The fasting test differentiates osmotic from secretory: Osmotic diarrhea (lactose intolerance, sorbitol, magnesium) stops with fasting; secretory diarrhea continues regardless of oral intake.
Nocturnal diarrhea suggests organic disease: Functional disorders like irritable bowel syndrome rarely wake patients from sleep. Nocturnal symptoms warrant investigation for inflammatory bowel disease, diabetic autonomic neuropathy, or microscopic colitis.
Microscopic colitis requires biopsy: The colon appears grossly normal on colonoscopy. Always obtain random biopsies in older adults with chronic watery diarrhea, even if mucosa looks normal.
Fecal calprotectin is an excellent screening tool: A normal fecal calprotectin (<50 μg/g) has a high negative predictive value for inflammatory bowel disease and can help avoid unnecessary colonoscopy in young patients.
Check total IgA with celiac serology: Approximately 2-3% of celiac patients have IgA deficiency, which causes false-negative tissue transglutaminase IgA results. Always order total IgA simultaneously.
Post-infectious irritable bowel syndrome is common: Up to 10-15% of patients develop chronic symptoms after acute gastroenteritis. Reassure patients this typically improves over weeks to months.
Oral rehydration solution is superior to plain water: The sodium-glucose cotransporter remains functional even in secretory diarrhea. ORS with balanced electrolytes is more effective than water, sports drinks, or juice for rehydration.
Metformin is a very common cause: Diarrhea affects up to 50% of patients on metformin. It often improves with time, extended-release formulation, or dose adjustment. Always consider this before extensive workup in diabetic patients.
Critical Pitfalls to Avoid
Giving antibiotics for E. coli O157:H7: Antibiotics increase the risk of hemolytic uremic syndrome in Shiga toxin-producing E. coli infections. Avoid empiric antibiotics in afebrile bloody diarrhea, especially with recent ground beef exposure.
Using loperamide in invasive colitis: Antidiarrheal agents are contraindicated in bloody diarrhea, fever, or suspected Clostridioides difficile infection. They can precipitate toxic megacolon or prolong pathogen clearance.
Stopping Clostridioides difficile treatment too early: Complete the full course (10-14 days of vancomycin). Stopping early increases recurrence risk. Also, do not repeat C. difficile testing to document cure — test only if symptoms recur.
Attributing all diarrhea in antibiotic users to C. difficile: Antibiotic-associated diarrhea is often non-C. difficile (simple microbiome disruption). Only test symptomatic patients with liquid stools, and interpret positive results in clinical context.
Missing microscopic colitis due to lack of biopsies: The mucosa looks normal. If you do not biopsy, you will miss the diagnosis. Always obtain random biopsies in chronic watery diarrhea workup.
Diagnosing celiac disease on a gluten-free diet: Serology and histology may normalize after gluten elimination. Ensure patient is eating gluten-containing foods for at least 2-4 weeks before testing.
Overlooking medication-induced causes: Always review the complete medication list including over-the-counter drugs, supplements, and herbal products. Metformin, PPIs, NSAIDs, SSRIs, magnesium, and many others cause diarrhea.
Assuming normal colonoscopy excludes all pathology: Small bowel diseases (Crohn’s, celiac, SIBO, Whipple’s) and functional disorders are not visible on colonoscopy. Consider upper endoscopy, capsule endoscopy, or cross-sectional imaging when indicated.
Failing to consider multiple overlapping causes: Chronic diarrhea often has more than one contributing factor. A patient may have bile acid malabsorption AND lactose intolerance. Address each component.
Underestimating dehydration in the elderly: Older adults have reduced thirst sensation and physiological reserve. They can become severely dehydrated before clinical signs are obvious. Have a low threshold for IV fluids.
Key Takeaways
- Duration guides your approach: Acute (<14 days) is usually infectious and self-limiting; chronic (>4 weeks) requires systematic investigation based on stool type (watery, inflammatory, fatty).
- Red flags demand action: Bloody diarrhea, severe dehydration, high fever, recent antibiotics/hospitalization, immunocompromise, and unintentional weight loss require prompt evaluation and often hospitalization.
- Hydration is the cornerstone of treatment: Most acute diarrhea morbidity comes from dehydration. Oral rehydration solution is effective in most cases; IV fluids for moderate-severe dehydration.
- Most acute diarrhea does not need testing or antibiotics: Reserve stool studies for severe, bloody, prolonged (>7 days), or high-risk cases. Antibiotics are rarely needed and can cause harm.
- Clostridioides difficile should always be considered: In any patient with diarrhea and recent antibiotic exposure, hospitalization, or healthcare contact within the past 3 months.
- The “Big Four” dominate chronic diarrhea: Irritable bowel syndrome-diarrhea predominant, bile acid malabsorption, malabsorption syndromes (celiac, pancreatic insufficiency), and microscopic colitis account for the majority of cases.
- Empiric treatment trials are valuable diagnostic tools: Lactose elimination, bile acid sequestrants, and rifaximin for SIBO can both diagnose and treat common conditions without invasive testing.
- Normal colonoscopy is not the end of the workup: Microscopic colitis requires biopsies; small bowel pathology requires upper endoscopy, capsule endoscopy, or imaging; functional disorders are diagnoses of exclusion.
- Medication review is essential: Drug-induced diarrhea is common and treatable. Review the complete list including over-the-counter products and supplements in every patient with chronic diarrhea.
- Consider the mechanism: Understanding whether diarrhea is secretory (continues with fasting), osmotic (stops with fasting), inflammatory (blood/mucus), or fatty (steatorrhea) guides targeted investigation and treatment.
Quick Reference Algorithm
Systematic Approach to Diarrhea:
- Assess urgency: Check hydration status, vital signs, and red flags. Stabilize if needed.
- Classify by duration: Acute (<14 days), persistent (14-28 days), or chronic (>4 weeks)?
- For acute diarrhea: Focus on hydration; test only if bloody, febrile, prolonged, or high-risk; avoid antibiotics unless indicated.
- For chronic diarrhea: Review medications; basic labs (CBC, CMP, TSH, celiac serology, fecal calprotectin); classify stool type.
- Target investigation by mechanism: Osmotic (dietary trials), secretory (bile acid sequestrant trial, colonoscopy with biopsies), inflammatory (colonoscopy), fatty (fecal elastase, celiac workup).
- Consider empiric treatment trials: Lactose elimination, bile acid sequestrant, rifaximin for SIBO — response is both diagnostic and therapeutic.
- Refer for endoscopy when indicated: Alarm features, age ≥45-50, elevated calprotectin, failed empiric therapy, need for biopsy.
- Reassess if refractory: Re-review medications, ensure biopsies were obtained, consider overlapping causes, rare diagnoses, or specialist referral.